...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: A Speculative Theory

"If ZC is sold or does a big deal, the cash should be doled out to shareholders."

ZE ZE ZE.  Not ZC.

Share
New Message
Please login to post a reply